HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Doris Mayr Selected Research

L-161982

3/2021EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Doris Mayr Research Topics

Disease

95Neoplasms (Cancer)
01/2022 - 04/2003
37Breast Neoplasms (Breast Cancer)
09/2021 - 09/2004
35Ovarian Neoplasms (Ovarian Cancer)
02/2022 - 06/2003
26Carcinoma (Carcinomatosis)
01/2022 - 06/2003
14Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2021 - 01/2011
12Endometrial Neoplasms (Endometrial Cancer)
11/2021 - 07/2003
12Carcinogenesis
03/2021 - 06/2003
11Ovarian Epithelial Carcinoma
01/2022 - 10/2012
10Inflammation (Inflammations)
01/2022 - 06/2003
8Neoplasm Metastasis (Metastasis)
08/2021 - 06/2011
7Fibrosis (Cirrhosis)
01/2022 - 03/2007
6Granulosa Cell Tumor
02/2021 - 01/2008
4Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 03/2016
4Adenocarcinoma
12/2019 - 06/2003
4Endometriosis
02/2018 - 11/2012
3Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 06/2003
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 05/2010
3Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2019 - 07/2007
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2015 - 08/2011
3Pre-Eclampsia (Preeclampsia)
09/2008 - 02/2007
3HELLP Syndrome
09/2008 - 02/2007
2Microsatellite Instability
11/2021 - 07/2021
2Vulvar Neoplasms (Vulvar Cancer)
03/2021 - 12/2020
2Colitis
01/2021 - 01/2019
2Uterine Cervical Dysplasia
07/2020 - 01/2017
2Squamous Cell Carcinoma of Head and Neck
04/2020 - 05/2010

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
11/2021 - 07/2006
18ParaffinIBA
08/2020 - 09/2004
11Estrogen ReceptorsIBA
11/2021 - 11/2012
11Hormones (Hormone)IBA
08/2021 - 05/2009
11Mucin-1 (CA 15-3 Antigen)IBA
02/2021 - 07/2007
9Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2012
8CateninsIBA
06/2021 - 07/2013
8Formaldehyde (Formol)FDA Link
07/2020 - 09/2004
7DNA (Deoxyribonucleic Acid)IBA
11/2020 - 07/2006
7AntibodiesIBA
01/2019 - 02/2009
7Monoclonal AntibodiesIBA
06/2012 - 06/2003
6GTP-Binding Proteins (G-Protein)IBA
11/2021 - 11/2012
6Small Interfering RNA (siRNA)IBA
11/2021 - 03/2013
6AntigensIBA
10/2018 - 07/2007
6Cadherins (E-Cadherin)IBA
10/2018 - 09/2004
6CarbohydratesIBA
01/2018 - 05/2010
5EnzymesIBA
11/2021 - 07/2007
5Galectins (Galectin)IBA
02/2021 - 05/2012
5Protein Isoforms (Isoforms)IBA
01/2021 - 10/2012
5Estrogens (Estrogen)FDA Link
01/2021 - 09/2008
5LigandsIBA
01/2021 - 10/2015
5Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
08/2020 - 01/2013
5EpitopesIBA
02/2020 - 05/2009
5Galectin 1 (LGALS1)IBA
10/2019 - 07/2007
5Messenger RNA (mRNA)IBA
01/2019 - 09/2004
5Oncogene Proteins (Oncogene Protein)IBA
10/2018 - 03/2009
4Histones (Histone)IBA
11/2021 - 02/2017
4Thyroid HormonesIBA
08/2021 - 10/2012
4Interleukin-1 (Interleukin 1)IBA
11/2020 - 08/2014
4Biological ProductsIBA
01/2020 - 06/2011
4Chemokine CCL22IBA
12/2019 - 11/2011
4FSH Receptors (FSH Receptor)IBA
10/2019 - 01/2013
41-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
06/2017 - 07/2007
4CA-19-9 Antigen (CA 19-9 Antigen)IBA
01/2017 - 07/2007
4GlycodelinIBA
12/2013 - 02/2009
3Sirtuin 1IBA
01/2022 - 08/2020
3Co-Repressor ProteinsIBA
11/2021 - 01/2019
3Immune Checkpoint InhibitorsIBA
11/2021 - 05/2019
3Lysine (L-Lysine)FDA Link
11/2021 - 03/2020
3histone H3 trimethyl Lys4IBA
11/2021 - 03/2020
3Bromodeoxyuridine (BrdU)IBA
03/2021 - 03/2020
3Calcitriol Receptors (Calcitriol Receptor)IBA
10/2020 - 02/2012
3Vitamin DFDA LinkGeneric
10/2020 - 10/2012
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2020 - 10/2012
3Indicators and Reagents (Reagents)IBA
12/2019 - 11/2016
3ProstaglandinsIBA
10/2019 - 01/2018
3progesterone receptor BIBA
01/2019 - 11/2012
3Carrier Proteins (Binding Protein)IBA
03/2018 - 06/2017
3Galectin 3 (LGALS3)IBA
10/2017 - 02/2011
3Sialyl Lewis X AntigenIBA
01/2017 - 07/2007
3GonadotropinsIBA
08/2014 - 01/2012
3Glycoproteins (Glycoprotein)IBA
07/2013 - 01/2007
3LH Receptors (LH Receptor)IBA
01/2013 - 05/2011
3Peptides (Polypeptides)IBA
10/2012 - 02/2009
3Tumor Biomarkers (Tumor Markers)IBA
09/2011 - 05/2010
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2022 - 02/2018
2Retinoid X Receptors (Retinoid X Receptor)IBA
01/2022 - 01/2017
2PlatinumIBA
01/2022 - 10/2020
2dostarlimabIBA
11/2021 - 07/2021
2pembrolizumabIBA
11/2021 - 07/2021
2RNA (Ribonucleic Acid)IBA
08/2021 - 03/2013
2human ERBB2 proteinIBA
08/2021 - 01/2020
2Trace amine-associated receptor 1IBA
08/2021 - 09/2017
2Prostaglandin Receptors (Prostaglandin Receptor)IBA
03/2021 - 01/2018
2Interleukin-10 (Interleukin 10)IBA
01/2021 - 01/2019
2Therapeutic UsesIBA
11/2020 - 01/2016
2Calcitriol (Calcijex)FDA LinkGeneric
03/2020 - 04/2015

Therapy/Procedure

30Therapeutics
04/2021 - 06/2003
8Drug Therapy (Chemotherapy)
10/2021 - 01/2009
5Mastectomy (Mammectomy)
01/2016 - 11/2008
4Immunotherapy
12/2019 - 06/2009
2Ischemic Postconditioning
01/2021 - 01/2019
2Ligation
01/2021 - 01/2019
2Breast Implants (Breast Implant)
04/2020 - 04/2013